AtriCure (ATRC) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
AtriCure Inc. (ATRC) PT Raised to $26 at Needham & Company Following 2Q Beat
July 28, 2017 8:07 AM EDTNeedham & Company raised its price target on AtriCure Inc. (NASDAQ: ATRC) to $26.00 (from $25.00) while maintaining a Buy rating following the company's 2Q. Revenue was $45.2M vs. consensus of $44.2M, EBITDA was ($0.4M) vs. consensus of ($1.9M), and EPS was ($0.21) vs. consensus of ($0.26).
For... More



